personalized medicine

Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study

Study Overview The study aims to evaluate and compare the effectiveness of three treatments—ripertamab, rituximab, and efgartigimod—administered to patients diagnosed […]

Comparative efficacy of ripertamab, rituximab, and efgartigimod in chronic inflammatory demyelinating polyneuropathy: an exploratory real-world multicenter cohort study Read Post »

Proteome-wide Mendelian Randomization and Colocalization Nominate CD58, PARP1, and Immune Co-stimulatory Pathways as Genetically Supported Targets for Multiple Sclerosis

Study Overview The research focused on exploring the genetic underpinnings of multiple sclerosis (MS) through advanced analytical methods, specifically Mendelian

Proteome-wide Mendelian Randomization and Colocalization Nominate CD58, PARP1, and Immune Co-stimulatory Pathways as Genetically Supported Targets for Multiple Sclerosis Read Post »

Para infectious myelitis with Conus medullaris immunotropism in the immune phase of leptospirosis infection: Clinical pattern and in silico molecular mimicry analysis based biological plausibility

Clinical Manifestations Individuals affected by para infectious myelitis in the context of leptospirosis often present with a variety of neurological

Para infectious myelitis with Conus medullaris immunotropism in the immune phase of leptospirosis infection: Clinical pattern and in silico molecular mimicry analysis based biological plausibility Read Post »

Scroll to Top